Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Myopathies

Staff  |  Issue: May 2009  |  May 1, 2009

Myopathy is the medical term for muscle disease. Patients with myopathy develop weakness in the large muscles around the neck, shoulders, and hips. This causes difficulty in climbing stairs, getting up from a chair or toilet seat, or reaching for objects overhead. Some patients with myopathy develop weakness of the throat muscles involved in swallowing, and this may cause choking or aspiration of food into the lungs when eating. Others may experience shortness of breath and cough due to inflammation of the lungs.

Two types of inflammatory myopathies are polymyositis and dermatomyositis. Polymyositis is an inflammation of the muscle tissue that leads to weakness, and dermatomyositis is characterized by immune inflammation of muscles, as well as by the presence of a rash. This rash, which appears as a purple or red discoloration of the upper eyelids, is present in almost all children with inflammatory myopathy. “People with dermatomyositis may also have lung inflammation (pneumonitis), and children may have an inflammation of the blood vessels and calcium deposits in the skin referred to as calcinosis,” explains patient fact sheet author Marc Miller, MD, of Rheumatology Associates in Portland, Maine.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Inflammatory myopathies are rare diseases, and polymyositis and dermatomyositis occur in approximately one person in 100,000. All age groups are affected, with peak incidence between the ages of five and 10 in children and between the ages of 40 and 50 in adults. Women are affected about twice as often as men, all ethnic groups are affected, and it is not possible at this time to predict who will develop an inflammatory myopathy.

A diagnosis of myopathy is suspected when patients complain of difficulty performing tasks that require muscle strength or when they develop certain rashes or respiratory problems. To establish a diagnosis, perform a muscle-strength examination to determine if true muscle weakness is present. This likely will be followed by a blood test to measure the level of various muscle enzymes, an electromyogram to gauge electrical activity in muscle, and finally a biopsy of a weak muscle. Sometimes MRI scanning can help to establish the presence of abnormal muscle.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Treatment depends on the type of myopathy diagnosed. Polymyositis and dermatomyositis are usually treated with medications. An oral corticosteroid, such as prednisone, is usually administered in high doses once the diagnosis has been established. “Methotrexate or azathioprine are usually added to ensure better long-term control of the disease and to avoid long-term side effects of cortisone,” explains Dr. Miller. In severe or treatment-resistant cases, additional measures may include intravenous immunoglobulin and other immunosuppressive medications.

Since the myopathies are chronic diseases, it is important for patients to practice good general health measures, including a well-balanced nutritional diet, maintenance of normal weight, and proper management of any other chronic illnesses. Physical therapy and regular exercise to regain and maintain muscle strength are also important in the treatment of myopathy.

Download the complete myopathies fact sheet and other patient-education materials at www.rheumatology.org by following the links to patient education from the Practice Support Menu.

Page: 1 2 | Multi-Page
Share: 

Filed under:From the College Tagged with:DiagnosisMyopathiesPatient Fact SheetTreatment

Related Articles

    New Tools for Myositis Diagnosis, Classification & Management

    April 15, 2019

    courtesy ACR Daily News CHICAGO—At Hot Topics in Myositis, a session at the 2018 ACR/ARHP Annual Meeting, three experts discussed new classification criteria for idiopathic inflammatory myopathies (IIM) and offered practical primers on overlap myositis conditions and inclusion body myositis (IBM). New Myositis Classification Criteria After a 10-year development process, the new EULAR/ACR Classification Criteria…

    AJPhoto / Science Source

    Tips for Diagnosing Metabolic Myopathies

    September 17, 2019

    AJPhoto / Science Source When evaluating patients with possible myopathic symptoms, rheumatologists must consider a rare, but important, group of inherited disorders: the metabolic myopathies. However, their diagnosis often remains a challenge. Early recognition of these primary metabolic myopathies is essential to help prevent disease morbidity and mortality from rhabdomyolysis. Here, we focus on the…

    Diagnosis: Myopathy

    July 1, 2009

    Presentation and evaluation of metabolic causes

    Inflammatory Myopathies Difficult to Diagnose, Treat

    December 1, 2013

    Without a single set of diagnostic criteria for identifying polymyositis, dermatomyositis, or myositis and scant evidence-based therapeutic guidelines, these rare muscle diseases can be hard to manage

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences